Comparison of early salvage and adjuvant radiotherapy for non-organ-confined prostate cancer after radical prostatectomy by F. Preisser, R.S. Pompe, F.K.H. Chun, M. Graefen, H. Huland, D. Tilki

Get full text

Risk of metastasis in patients with delayed biochemical recurrence 10 years after radical prostatectomy by F. Preisser, R.S. Pompe, F.K.H. Chun, M. Graefen, H. Huland, D. Tilki

Get full text

Effect of tumor characteristics on functional outcomes after radical prostatectomy by L.F. Stolzenbach, R.S. Pompe, F. Preisser, S. Knipper, M. Graefen, H. Huland, D. Tilki

Get full text

Analysis of small non-coding RNAs in urinary exosomes accurately classifies prostate cancer into low grade (GG1) and higher grade (GG2-5) by L.H. Klotz, D. Tilki, N. Fleshner, A.G. Dirienzo, W.L.W. Wang, M. Tenniswood

Get full text

Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer by R.S. Pompe, F. Preisser, S. Leyh-Bannurah, P. Gild, G. Salomon, M. Graefen, M. Fisch, H. Huland, D. Tilki

Get full text

Impact of adjuvant radiotherapy in patients with high burden lymph node metastases after radical prostatectomy by R.S. Pompe, F. Preisser, P. Gild, P. Mandel, T. Steuber, G. Salomon, M. Graefen, H. Huland, M. Fisch, D. Tilki

Get full text

Halving the risk of symptomatic lymphoceles after radical prostatectomy: Results of a randomised-controlled study including 1080 patients by U.H.G. Michl, A. Haese, H. Heinzer, G. Salomon, T. Steuber, L. Budäus, D. Tilki, H. Isbarn, T. Maurer, P. Tennstedt, M. Graefen

Get full text

Early urinary continence a reliable marker for further functional outcomes by R.S. Pompe, F. Preisser, P. Gild, P. Mandel, S.R. Leyh-Bannurah, G. Salomon, M. Graefen, H. Huland, M. Fisch, D. Tilki

Get full text

Salvage radiotherapy versus observation for biochemical recurrence following radical prostatectomy for prostate cancer: A matched pair analysis by F. Preisser, T. Wiegel, D. Bartkowiak, R.S. Pompe, F.K.H. Chun, M. Graefen, A. Siegmann, D. Böhmer, V. Budach, H. Huland, D. Tilki

Get full text

The effect of age on cancer-specific mortality in patients with prostate cancer: A population-based study across all stages by S. Knipper, A. Pecoraro, C. Palumbo, G. Rosiello, S. Luzzago, M. Deuker, Z. Tian, S.F. Shariat, F. Saad, D. Tilki, M. Graefen, P.I. Karakiewicz

Get full text

EAU BCR risk classification as decision tool for salvage radiatiotherapy by R.S. Pompe, T. Wiegel, D. Bartkowiak, F. Preisser, S. Leyh-Bannurah, P. Gild, G. Salomon, M. Graefen, A. Siegmann, D. Böhmer, V. Budach, M. Fisch, H. Huland, D. Tilki

Get full text

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection by G. Gandaglia, A. Martini, G. Ploussard, N. Fossati, N. Suardi, A. Stabile, F. Dehò, M. Droghetti, P.I. Karakiewicz, P. De Visschere, H. Borgmann, I. Heidegger, A. Kretschmer, R. Mathieu, C. Surcel, D. Tilki, I. Tsaur, M. Valerio, R. Van Den Bergh, P. Ost, F. Montorsi, A. Briganti

Get full text

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. The importance of patient st... by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection by S. Scuderi, G. Gandaglia, A. Martini, G. Ploussard, N. Fossati, N. Suardi, A. Stabile, F. Dehò, M. Droghetti, P.I. Karakiewicz, P. De Visschere, E. Borgmann, I. Heidegger, A. Kretschmer, M. Roumiguiè, C. Surcel, D. Tilki, I. Tsaur, M. Valerio, R. Van Der Bergh, P. Ost, F. Barletta, F. Montorsi, A. Briganti

Get full text

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. The importance of an extensive, multi-modal ap... by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter study by G. Marra, P. Gontero, G. Calleris, M. Oderda, C. Filippini, R. Sanchez-Salas, S. Goonewardene, R. Popert, D. Cahill, R. Persad, J. Palou, S. Joniau, A. De La Taille, M. Roupret, S. Albisinni, A. Morlacco, G. Gandaglia, A. Mottrie, J. Smith, I.S. Gill, H. Van Der Poel, D. Tilki, D. Murphy, J. Davis, R.J. Karnes

Get full text

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? Results from a large, multi-institution... by C.A. Bravi, N. Fossati, R.J. Karnes, G. Motterle, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K-P. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient st... by A. Martini, N. Fossati, G. Gandaglia, C.A. Bravi, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institution... by C.A. Bravi, N. Fossati, G. Gandaglia, A. Martini, R.J. Karnes, G. Motterle, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal ap... by C.A. Bravi, N. Fossati, G. Gandaglia, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, A. Martini, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text